Swiggy Instamart-PharmEasy’s 10-minute medicine pilot resurfaces amid chemist body scrutiny from a November 2024 move
Resurfacing a November 2024 move, the All India Organisation of Chemists and Druggists had asked the drug regulator to review the Delhi pilot, flagging prescription validation, customer identity, counterfeit and storage risks. Swiggy Instamart and PharmEasy say the service uses traceable, stringent supply-chain controls.
What happened
AIOCD asked the DCGI to review Swiggy Instamart and Pharmeasy’s 10-minute medicine-delivery pilot, citing prescription, identity, counterfeit and storage risks.
Key facts
- 10 minutes
Why this matters
Prioritize partnerships or acquisitions that add licensed pharmacy networks, digital prescription validation, anti-counterfeit traceability and controlled-storage capabilities to build a defensible rapid-delivery platform.